Galectin Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
(NASDAQ:GALT) NORCROSS, Ga., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today announced th...
13 days ago